NovaBridge Biosciences Treasury Stock, Value, Acquired, Cost Method
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- NovaBridge Biosciences treasury stock, value, acquired, cost method for the quarter ending 2024-12-31 was $0.00.
- NovaBridge Biosciences treasury stock, value, acquired, cost method for the quarter ending 2024-09-30 was $0.00.
| Period end | Treasury Stock, Value, Acquired, Cost Method 3 month | Treasury Stock, Value, Acquired, Cost Method 12 month |
|---|---|---|
| 2024-12-31 | $0.00 derived: 20-F 12 month − 6-K 9 month · filed 2026-04-07 | $335.00K 20-F · filed 2026-04-07 |
| 2024-09-30 | $0.00 derived: 6-K 9 month − 6-K 6 month · filed 2025-12-18 | |
| 2023-12-31 | 61.26M CNY 20-F · filed 2024-04-30 | |
| 2023-12-31 | $8.64M 20-F · filed 2026-04-07 | |
| 2022-12-31 | 21.25M CNY 20-F · filed 2024-04-30 | |
| 2022-12-31 | $3.01M 20-F · filed 2025-04-03 |